Clinical Trials Show New Flu Drug Safe and Effective: Japanese Drugmaker

by VR Sreeraman on  August 10, 2009 at 6:11 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

A new flu drug under development has been shown to be as safe and effective as Tamiflu in clinical trials, Japanese pharmaceutical maker Daiichi Sankyo Co. said Monday.
Clinical Trials Show New Flu Drug Safe and Effective: Japanese Drugmaker
Clinical Trials Show New Flu Drug Safe and Effective: Japanese Drugmaker

The drug, known as CS-8958 or Laninamivir, demonstrated the same level of efficacy as Tamiflu for adults and was even more effective among children, the company said in a statement.

Laninamivir, co-owned with Australia's Biota Holdings Ltd., is expected to be effective for treating seasonal and swine flu, and has also shown efficacy against the H5N1 avian flu virus in non-clinical tests, it said.

"Laninamivir offers a new therapeutic agent in the treatment of influenza with particular advantages for stockpiling applications," Biota managing director Peter Cook said in a separate statement.

Daiichi said it would apply to regulators by March for approval to sell the drug in Japan, where it has the marketing rights. A licensing partner is being sought for all other markets.

Sales of Tamiflu, made by Swiss pharmaceutical giant Roche, have soared following the emergence of the A(H1N1) swine flu virus and its rapid spread around the world to pandemic levels.

Source: AFP
SRM

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Swine Flu Placebo Effects: Rare Insights 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive